Project locations
- Nashik
- Dindori
- Chhattisgarh
- Rewa
- Chhatisgarh
- Haryana, Delhi
- Nagpur
- Gumbhali
- Karnataka
- Andhra Pradesh
- Pondicherry
Pulmonary Function Test (PFT), a GOLD standard for CRD screening and diagnosis is costly and inaccessible - at community level - requires trained man power to conduct and requires trained pulmonologist to interpret the results. Hence PFT becomes a privileged test – Briota’s PFT In A Box™ makes PFT available, affordable and accessible for ALL.
Smoking including passive smoking accounts for as many as 8 out of 10 COPD-related deaths. Briota through it's program SAVE™ (Spirometry Assisted Virtually Early) not only helps with screening and diagnosis, but also creates awareness about risks of smoking. Our volunteers and trained technicians help people make healthier choices.
Briota has partnered with various organisations including MPBCDC to generate local employment opportunities especially for women in rural and tribal areas. Briota selects, trains and employs the local volunteers at village level to work with Briota's qualified PFT Technicians.
Briota is a for profit impact organisation on a global mission to complete 100 Million Screenings for NCDs (Non Communicable Diseases) by 2030 ! Briota's POCT (point of care testing) platform - SURAKSHA (सुरक्षा) covers 12 NCDs - Anemia, Asthma/COPD, Post TB Lung Disease, Cardio Vascular Diseases (STEMI), Diabetes, Breast Cancer, Oral Cancer, Cervical Cancer, Lung Cancer, NAFLD/Chronic Liver Disease, Chronic Kidney Disease, Epilepsy. SURAKSHA (सुरक्षा) is specially designed for primary care and community care. Briota operates in 6 states in India and has presence in Denmark, USA, Philippines, Bangladesh and Kenya..
Watch Video
BreastPRO offers accessible breast cancer screening at the PHC level, reducing barriers to early detection and treatment.
The portability and compact design of SpiroPRO make it suitable for use in resource-limited PHC settings, where space may be constrained.
SpiroPRO is designed for ease of use, allowing healthcare workers at PHC facilities to perform spirometry tests accurately and efficiently.
Training programs on spirometry testing with SpiroPRO enhance the capacity of healthcare workers at PHC centers, strengthening the primary healthcare workforce.
SpiroPRO screenings facilitate collaboration with chest physicians and specialists for further evaluation and management of individuals at high risk for lung cancer.
BreastPRO offers accessible breast cancer screening at the PHC level, reducing barriers to early detection and treatment.
With its user-friendly design and simplified operation, BreastPRO can be effectively utilized by healthcare workers with varying levels of expertise.
BreastPRO enables quick assessment of breast abnormalities, allowing for prompt referral and further diagnostic evaluation if necessary.
BreastPRO screenings encourage community engagement and participation in breast cancer awareness initiatives, fostering a culture of proactive healthcare-seeking behavior.
By integrating BreastPRO into women's health services at PHC facilities, healthcare providers can offer comprehensive preventive care to women of all ages.
BreastPRO facilitates data collection on breast cancer prevalence and risk factors, contributing to evidence-based planning and resource allocation for breast cancer control programs.
BreastPRO screenings empower women with knowledge about breast health and self-examination techniques, empowering them to take charge of their own health.
KidneyPRO enables early detection of Chronic Kidney Disease (CKD) through comprehensive renal function assessments at the PHC level.
As a point-of-care testing device, KidneyPRO provides immediate results, allowing for prompt initiation of interventions to slow disease progression.
KidneyPRO offers patient-friendly testing procedures, minimizing discomfort and promoting compliance with screening recommendations.
By integrating KidneyPRO screenings into routine health check-ups at PHC facilities, healthcare providers can offer integrated care for individuals at risk for CKD.
KidneyPRO screenings provide an opportunity for preventive education on kidney health, including lifestyle modifications and medication adherence, to delay CKD progression.
KidneyPRO facilitates monitoring of disease progression in individuals with known risk factors for CKD, enabling timely adjustments to treatment plans.
KidneyPRO screenings establish clear referral pathways for individuals identified with CKD, ensuring timely access to specialized care and support services.
Neodocs partners with Briota Technologies to introduce the innovative Kidney Pro device.
OralPRO offers a non-invasive method for early detection of oral cancer, making it suitable for use at PHC facilities where invasive procedures may not be feasible.
With OralPRO, healthcare providers can obtain rapid results, enabling timely intervention and reducing the need for referrals to higher-level facilities.
OralPRO is user-friendly and requires minimal training, making it accessible to healthcare workers at PHC centers.
As a cost-effective screening tool, OralPRO allows PHC facilities to maximize their resources while addressing the significant burden of oral cancer in the community.
The portability of OralPRO facilitates community outreach programs, bringing oral cancer screening services directly to underserved populations.
The portability of OralPRO facilitates community outreach programs, bringing oral cancer screening services directly to underserved populations.
By integrating OralPRO into existing PHC services, healthcare providers can offer comprehensive healthcare solutions tailored to the community's needs.
HaemoPRO offers point-of care diagnosis of anemia through rapid hemoglobin analysis at the PHC level, allowing for immediate identification and intervention.
HaemoPRO brings anemia screening services closer to communities, particularly in remote or underserved areas where access to laboratory facilities may be limited.
By providing immediate hemoglobin results, HaemoPRO facilitates timely intervention with iron supplementation, dietary modifications, or further diagnostic evaluation for underlying causes of anemia.
HaemoPRO screenings enable targeted interventions for high-risk groups, such as pregnant women and children, to prevent complications associated with anemia.
HaemoPRO screenings serve as an opportunity for health education on anemia prevention and management, empowering individuals to adopt healthy lifestyle practices
By integrating HaemoPRO screenings into maternal and child health services at PHC facilities, healthcare providers can address anemia as part of routine antenatal and postnatal care.
HaemoPRO facilitates monitoring the effectiveness of interventions for anemia management, allowing healthcare providers to track progress and adjust treatment plans as needed.
The Insulin Meter offers point-of-care blood glucose monitoring for diabetes screening at the PHC level, enabling immediate assessment and intervention.
Insulin Meter screenings enhance access to diabetes screening services, particularly in rural or remote areas where laboratory facilities may be scarce.
Insulin Meter screenings empower individuals with diabetes to monitor their blood glucose levels regularly, promoting self-management and lifestyle modifications.
By detecting hyperglycemia early, Insulin Meter screenings facilitate early intervention with lifestyle modifications, medication, and regular follow-up care to prevent diabetes-related complications.
Insulin Meter screenings can be integrated into chronic disease management programs at PHC facilities, allowing for comprehensive care for individuals with diabetes.
Insulin Meter screenings raise awareness about the importance of diabetes prevention and control, encouraging community-wide efforts to adopt healthier lifestyles and reduce diabetes risk factors.
Insulin Meter screenings contribute to data collection for diabetes surveillance and monitoring trends in diabetes prevalence, guiding public health interventions and resource allocation strategies
"At Briota Technologies, we're revolutionizing healthcare access with our NCD POCT devices. Our mission is to empower communities by providing accurate and timely screening for non-communicable diseases. With our innovative solutions, we aim to bridge the gap in healthcare delivery, ensuring early detection and intervention for better health outcomes."
India firmly emphasizes the need for a comprehensive strategy which includes preventive measures, early discussion and efficient management with the aim of reducing the prevalence and impact of NCDs on the well-being of our citizens. “Scaling up Integration of NCDs in Primary Care”
At the inauguration ceremony of the NCD Health Camp at Rewa District Hospital, organized by the National Health Mission (NHM) Madhya Pradesh, Deputy Chief Minister Shri Rajendra Shukla expressed his deep commitment to addressing the challenges posed by Non-Communicable Diseases (NCDs), particularly chronic respiratory diseases like COPD and asthma. His speech underscored the importance of early detection and management, reflecting his proactive stance on public health.
Briota has won several national and international awards and grants including MIT Solve 2023, BIRAC, JanCare Government of India Top 20 Startup, ZS PRIZE Most Disruptive Healthcare Company 2023 and OPPI Most Innovative Medtech Startup 2021
